ASSET ACQUISITION (Tables)

3 Months Ended

Mar. 31, 2026

Asset Acquisition [Abstract]

Schedule of total consideration transferred was allocated to the acquired assets

Asset		Allocated Cost
Cash acquired		$	6,500
Prepaid clinical trial services asset		$	975
In-process research and development (“IPR&D”)		$	4,947
Total		$	12,422